ISTH 2022 Congress
Fibrinolysis and Proteolysis
Theme Navigation
-
Abstract Number: PB0644
Effect of Novel Thrombolytic Aptamer DTRI-031 on Microfluidic Thrombolysis and VWF Function Dose-Response
-
Abstract Number: VPB0638
Effects of Clot Contraction on Clot Degradation: A Mathematical and Experimental Approach
-
Abstract Number: OC 46.1
Fibrin Film Formation is Enhanced by Red Blood Cells and Reduces Platelet Spreading
-
Abstract Number: OC 29.3
Fibrinogen αC-Connector is Critical for Fibrin Fiber Assembly and Mechanical Strength
-
Abstract Number: OC 76.1
Functional characterization and structural modeling of DNA-aptamers targeting activated coagulation Factor XIII
-
Abstract Number: PB0627
Hypofibrinolysis in patients with aortic stenosis is driven by overexpression of plasminogen activator inhibitor type 1 (PAI- 1) associated with elevated oxidized lipoproteins
-
Abstract Number: PB0625
Influence of centrifugation and residual platelet count on PAI-1 plasma level, euglobulin clot lysis time and global fibrinolytic capacity of plasma
-
Abstract Number: PB0620
Low molecular weight heparin slows the formation of clots from patients within twenty-four hours of acute PE
-
Abstract Number: VPB0645
Modulation of plasmin inhibitor activities, using Affimer technology, improves the hypofibrinolytic environment in high vascular risk individuals
-
Abstract Number: OC 76.3
Molecular Basis for the Conformational Selectivity of Thrombomodulin for TAFI or Protein C
-
Abstract Number: OC 46.2
Neutrophil Cathepsin G Cleaves Fibrinogen Affecting Clot Structure
-
Abstract Number: PB0626
Plasminogen deficiency: a case series of an ultra-rare disease in a Spanish centre
-
Abstract Number: PB0623
Role of Transglutaminase 2 in Haemostasis and as a Novel Treatment Option for Acquired Autoimmune Factor XIII Deficiency
-
Abstract Number: OC 46.1
Streptococcal Surface Enolase (SEN) is Overshadowed by Plasminogen-binding Group A Streptococcal M-protein (PAM) for Human Plasminogen Acquisition and Activation
-
Abstract Number: VPB0639
Strong Fibrinolysis with New Fermented Foods (Mung Bean Natto and Natto Miso)
-
Abstract Number: OC 29.2
Surface exposure of cellular factor XIII on activated platelets and platelet microparticles is unrelated to the elevation of cytoplasmic Ca2+ concentration
-
Abstract Number: PB0628
The characterization of clot-fibrinolysis waveform analysis and the investigation of usefulness in critical care patients with enhanced or suppressed fibrinolysis
-
Abstract Number: PB0642
The use of plasminogen activator inhibitor-1 specific Affimers as a tool to modulate fibrin clot properties and thrombosis risk
-
Abstract Number: PB0629
The validation of new global fibrinolysis capacity assays in high tPA concentration situation and the comparison with thromboelastgraphy
-
Abstract Number: VPB0646
Thrombolytic therapy in pulmonary embolism patients with thrombocytopenia: a systematic review